Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy (2021)
- Authors:
- Autor USP: SILVA, THIAGO APARECIDO DA - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.jcyt.2020.11.002
- Subjects: LINFÓCITOS T; FUNGOS; CRIPTOCOCOSE; IMUNOTERAPIA; POLISSACARÍDEOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Cytotherapy
- ISSN: 1465-3249
- Volume/Número/Paginação/Ano: v. 23, n. 2, p. 119-130, 2021
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
SILVA, Thiago Aparecido da et al. Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy. Cytotherapy, v. 23, n. 2, p. 119-130, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jcyt.2020.11.002. Acesso em: 29 dez. 2025. -
APA
Silva, T. A. da, Hauser, P. J., Bandey, I., Laskowski, T., Wang, Q., Najjar, A. M., & Kumaresan, P. R. (2021). Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy. Cytotherapy, 23( 2), 119-130. doi:10.1016/j.jcyt.2020.11.002 -
NLM
Silva TA da, Hauser PJ, Bandey I, Laskowski T, Wang Q, Najjar AM, Kumaresan PR. Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy [Internet]. Cytotherapy. 2021 ; 23( 2): 119-130.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.jcyt.2020.11.002 -
Vancouver
Silva TA da, Hauser PJ, Bandey I, Laskowski T, Wang Q, Najjar AM, Kumaresan PR. Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy [Internet]. Cytotherapy. 2021 ; 23( 2): 119-130.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.jcyt.2020.11.002 - Efeito da lectina ArtinM sobre as células T CD4+ murinas
- Efeito da lectiva imunomoduladora AffinM em células da imunidade adaptativa
- CAR T Cell-therapy for infectious diseases with emphasis on invasive fungal infections [Editorial]
- Titan cells and yeast forms of Cryptococcus neoformans and Cryptococcus gattii are recognized by GXMR-CAR
- Administration of artinm lectin reduces the severity of the acute phase infection with Trypanosoma cruzi
- The response of IL-17-producing B cells to ArtinM is independent of its interaction with TLR2 and CD14
- Modification of hinge/transmembrane and signal transduction domains improves the expression and signaling threshold of GXMR-CAR specific to Cryptococcus spp.
- Immunotherapeutic approaches for the treatment of Cryptococcus gattii infection by mannose-specific protein
- ArtinM: purification and evaluation of biological activities
- Expression of Hsp60 and its cell location in Paracoccidioides brasiliensis
Informações sobre o DOI: 10.1016/j.jcyt.2020.11.002 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003034390.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
